Patent AnalyticsExaminers
Menu

Application

17801757 · 3-((8-((1H-PYRAZOL-4-YL)AMINO)IMIDAZO[1,2-A]PYRIDIN-3-YL)ETHINYL)-N-PHENYLBENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

Filed 2022-08-23 · Granted · Patent 12673945 (2026-07-07) The official file ↗The patent and its PDF ↗ · Art unit 1624 · Examiner Bruck Kifle Easy · CPC A61P 35/00 · IMMUNOFORGE CO.,LTD. · KLARQUIST SPARKMAN, LLP

Office actions
3
first was Non-final rejection
RCEs
1
no appeal
To first action
32.3 mo
to disposition 46.5 mo
Statutes raised
112
3 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in